Innovalon, a data and analytics vendor for health care firms, filed for an IPO to raise as much as $500 million, an indication that 2015 valuations may be as absurd as 2014's were.
The FDA approved a significant number of new compounds in 2014, with the 41 novel medicines being second only to 1996's number. The bad news is that many of these drugs are specialty medications with very high price tags.
Modernizing Medicine is getting up-to-date by making an innovative acquisition of Aesyntix Physician Network, adding revenue cycle services to its EHR.
Looks like 2015 is going to be like 2014, sigh, a company called PocketDerm has raised $2.85 million for its tele-dermatology business that has patients send selfies of their skin conditions.
AMN Healthcare, which just in the last couple of weeks completed several acquisitions, is at it again, acquiring Avantas, a clinical labor management consultant, for up to $25 million.
Veridicus Health, a vendor of care management and pharmaceutical services, has acquired Global Pharmaceutical Solutions, which provides help to Medicare Part D programs.
https://veridicushealth.com/public/newsletter
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at khroche@healthy-skeptic.com.